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PREVALENS, KAEDAH RAWATAN, DAN KEPUASAN PESAKIT 
TERHADAP PENGURUSAN PENYAKIT BATU KARANG DI HOSPITAL 
UNIVERSITI SAINS MALAYSIA  
 
 
ABSTRAK 
 
Batu karang lazimnya terjadi disebabkan oleh pemendakan atau penghabluran 
mineral dan konstituen kencing. Ia adalah masalah biasa di seluruh dunia yang 
dimanifestasikan dengan episod kesakitan berulang, intervensi pembedahan serta 
penggunaan ubat yang menjejaskan kualiti hidup pesakit. Kajian ini bertujuan untuk 
menilai kebarangkalian penyakit batu karang di kalangan pesakit yang dimasukkan 
ke Hospital Universiti Sains Malaysia (HUSM), 2) - untuk menentukan ciri-ciri batu, 
cara rawatan, fungsi buah pinggang dan keadaan komorbid, 3) - untuk meneroka 
kepuasan pesakit dengan pengurusan penyakit batu karang, aspek sosial, persepsi, 
dan bagaimana penyakit yang mempengaruhi kualiti hidup mereka. Penyelidikan 
pelbagai kaedah, kuantitatif dan kualitatif digunakan. Bagi Fasa kuantitatif, reka 
bentuk kajian rentas keratan retrospektif telah di gunakan untuk mendapatkan data 
perlu bagi kajian  ini. Senarai semua pesakit yang dimasukkan ke HUSM selama 
lima tahun (1 Januari 2012 hingga 31 Disember 2016) telah diambil menggunakan 
pengkelasan ICD-10 untuk mengenal pasti kes-kes batu karang di HUSM. Analisis 
statistiks termasuk pengiraan statistik deskriptif, ujian Kolmogorov-Smirnov 
terhadap normaliti data kajian, dan ujian Mann-Whitney U untuk membandingkan 
median telah di guna pakai. Semua analisis dijalankan dengan program SPSS 
(Statistical Package of Social Sciences Version 22.0). Prevalens pesakit dengan 
penyakit batu karang adalah 1.8% di kalangan pesakit yang dimasukkan ke HUSM. 
Pesakit lelaki lebih daripada perempuan dengan nisbah 1.35: 1, majoriti pesakit 
xiv 
 
adalah dari etnik Melayu (91.1%, n = 133). “Litotripsy shockwave ekstracorporeal 
(ESWL)” adalah rawatan paling lazim digunakan di kalangan pesakit (45%, n = 67 
dari 146). Bagi fasa kualitatif. pendekatan fenomenologi telah diguna  pakai 
Pensampelan purposif digunakan untuk merekrut dan mendekati pesakit di atas 18 
tahun yang telah didiagnosis dengan penyakit batu karang. Wawancara separuh 
berstruktur telah dijalankan dengan pesakit dengan bertanya soalan siri terbuka. 
Wawancara yang dirakam suara adalah kata kerja yang ditranskripsikan dan 
diterjemahkan, maka analisis kandungan dijalankan. Wawancara dilakukan untuk 15 
pesakit dengan 8 lelaki dan 7 wanita berumur 24 hingga 79 tahun. Kepuasan 
terhadap pengurusan batu karang dipengaruhi oleh pilihan rawatan yang dipilih 
untuk setiap pesakit, jangkaan dan persepsi terhadap rawatan dan penyakit, dan isu 
berkaitan sistem penjagaan kesihatan. Memahami perspektif, pengalaman, dan 
pengetahuan pesakit batu buah pinggang boleh membantu dalam menyediakan 
penjagaan kesihatan yang lebih baik. Oleh kerana etiologi penyakit batu karang 
adalah bersifat pelbagai faktor, keperluan untuk maklumat lanjut mengenai pengaruh 
diet, iklim, perkauman perlu dilaksanakan. Adalah disyorkan untuk menjalankan 
kajian kebangsaan terperinci ke dalam epidemiologi, sosioekonomi, diet dan faktor-
faktor lain yang bertanggungjawab untuk wujudnya penaykit baru karang dalam 
kalangan rakyat di Malaysia. Apabila kajian sedemikian dijalankan, faktor-faktor ini 
dapat difahami secara mendalam bagi tujuan pencegahan bukan sahaja insiden tetapi 
juga morbiditi dan mortaliti yang sering dikaitkan dengan penyakit ini, Oleh itu, 
memahami pengaruh aspek sosial, persepsi dan kepuasan pesakit terhadap 
pengurusan batu karang membantu dalam menyediakan penjagaan yang sesuai dan 
pendidikan pesakit yang memastikan hasil kesihatan yang diharapkan. 
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PREVALENCE, MODES OF TREATMENT, AND PATIENTS’ 
SATISFACTION WITH KIDNEY STONE DISEASE MANAGEMENT AT 
HOSPITAL UNIVERSITI SAINS MALAYSIA 
 
 
ABSTRACT 
 
Kidney stones form by the precipitation or crystallization of minerals and 
urinary constituents. It is a common problem worldwide manifested with recurrent 
intermittent pain episodes, surgical interventions and medication consumption which 
affect the quality of life of the patients. This study aimed 1) - to assess the prevalence 
of kidney stone disease among patients admitted to Hospital Universiti Sains 
Malaysia (HUSM), 2) - to determine the characteristics of stones, modes of 
treatment, renal function and comorbid conditions, 3) - to explore the patients’ 
satisfaction with the management of kidney stones disease, the social aspects, 
perceptions, and how the disease affecting their quality of life. A multi-method 
research adopting both quantitative and qualitative methodologies were applied. 
Quantitative phase was a retrospective cross-sectional study design. A list of all 
patients admitted to HUSM for five years (January 1st, 2012 to December 31st, 2016) 
was retrieved using ICD-10 to identify cases of kidney stones in HUSM. The 
statistical analysis included the calculation of descriptive statistics, Kolmogorov-
Smirnov test of normality, and Mann–Whitney U test to compare medians. All 
analysis were carried out with SPSS (Statistical Package of Social Sciences Version 
22.0) program. The prevalence of patients with kidney stones disease was 1.8% 
among patients admitted to HUSM. Male patients were more than females with a 
ratio of 1.35:1, the majority of patients were of Malay ethnicity (91.1%, n= 133). 
Extracorporeal shockwave lithotripsy was the most prevalent mode of treatment 
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among patients (45%, n= 67 of 146). On the other hand, a phenomenological 
approach was applied in the qualitative phase. Purposive sampling was adopted to 
recruit and approach patients above 18 years old and diagnosed with kidney stones 
disease. Face-to-face semi-structured interviews were conducted with patients by 
asking series of open-ended questions. The voice-recorded interviews were verbatim 
transcribed and translated, then content analysis was carried out. Interviewing was 
done for 15 patients with 8 male and 7 female of age 24 to 79 years old. The 
satisfaction towards the management of kidney stones was influenced by the 
treatment option chosen for each patient, expectations and perceptions of the 
treatment and disease, and healthcare system related issues. Understanding kidney 
stones patients’ perspectives, experiences, and knowledge can help in providing 
better proper health care. As the etiology of stones disease is multifactorial, the need 
for further information on dietetic, climatic, racial influences needs to be 
implemented. It is recommended to carry out a detailed national study into the 
epidemiology, socio-economic, dietary and other factors responsible for urolithiasis. 
When such a study is carried out and these factors understood that it may be possible 
to undertake preventive measures which will reduce not only the incidence but also 
the morbidity and mortality from urinary stones disease in the Malaysian population. 
Listening and investigate the stories about experiences and limitations of therapy is 
equally essential in the patient care. Hence, understanding the influence of social 
aspects, perceptions and patients’ satisfaction toward management of kidney stones 
help in providing appropriate care and patient-education that ensures the best 
expected health outcomes.   
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CHAPTER 1:  
INTRODUCTION 
1.1 Background 
Kidneys, two bean-shaped organs, function in essential roles to maintain the 
harmony of body systems. Kidneys maintain body fluid homeostasis, producing 
urine by clearing and removing excessive amounts of substances such as water, 
minerals, and waste products. Also, they reabsorb nutrients and synthesize certain 
hormones, such as erythropoietin, calcitriol, and renin.(Mukoyama and Nakao, 2005) 
Along with acid-base balance, blood pressure, electrolyte balance, and activation of 
vitamin D.(Atherton, 2015) 
The precipitation and accumulation of waste materials and minerals that are 
supposed to be washed out from the body lead to the formation of solid materials 
(crystals) inside kidneys or so-called stones. (Sakhaee, 2009) A kidney stone, or 
calculi, can be formed by the precipitation or crystallization of minerals and urinary 
constituents such as calcium oxalate, calcium phosphate, cystine or uric acid. 
The stones formed in the kidneys vary in size, big as a ball or small as a fine sand, it 
can migrate to any part of the urinary tract causing obstructions, symptoms of 
patients making them lye on the floor because of the pain or it can be asymptomatic 
where the patient can be surprised when the urine turned bloody, reddish, or sandy.  
Kidney stones disease, or urolithiasis, is a common problem worldwide with 
remarkable health and economic burden. It is regarded as a common cause of 
morbidity.(Alexander et al., 2012) After urinary tract infections and prostate 
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diseases, kidney stone disease is considered as the third most common disease in 
urology.(Yanagawa et al., 1997, Bartoletti et al., 2007). Urolithiasis is spreading all 
over the world with an increasing prevalence affecting males and females. However, 
it is more predominant in males compared to females with an average ratio of 2:1. 
(Xu et al., 2013).  
Humans have been suffering from kidney stones disease thousands and thousands of 
years back. (López and Hoppe, 2010, Shah and Whitfield, 2002) A fact that was 
confirmed by many archeologists and ancient writings that have passed through ages. 
In the 8th century B.C, an Indian surgeon described a surgery to treat kidney stones. 
Also, Hippocrates mentioned in his oath bladder stones, and he recommended not to 
cut patients and take out the stones.(Tefekli and Cezayirli, 2013) Historically, kidney 
stones used to be considered as a killer disease, many of the patients who suffered 
from painful stone colic ended up dead either because of the disease itself or the 
treatment method used back then. Treatment of kidney stones changed drastically 
through ages, from using open surgery, endoscopic interventions to recently most 
patients are being treated in outpatient settings with minimally invasive procedures, 
and patients getting treated using conservative approaches. (López and Hoppe, 2010, 
Shah and Whitfield, 2002). 
Therapy for urolithiasis has undergone many changes. The advent of non-invasive 
and minimal-invasive procedures has revolutionized the surgical approach to kidney 
stones treatment.(Türk et al., 2016c) However, the mode of treatment is 
individualized from patient to patient, as it depends on a variety of factors such as 
stone location, stone size, stone physicochemical properties, and patient’s 
preferences.  
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Patients with urolithiasis seek medical help usually complaining of renal colic. Renal 
colic is the acute cramping and intermittent abdominal and flank pain caused by 
kidney stones. The increased wall tension caused by urinary flow obstruction 
together with the contraction of the ureteral smooth muscle in an attempt to move the 
stone stimulates the synthesis of prostaglandins. This will cause inflammation, 
edema formation, and the painful spasms. Sometimes, it is accompanied by 
hematuria, nausea, and vomiting.(Golzari et al., 2014, Beltrami et al., 2016, Masarani 
and Dinneen, 2007, Ahmad et al., 1991)  
Aims of treatment are unified for all patients, preventing recurrence of stones and 
maintenance of renal function. (Eisner et al., 2013, Campschroer et al., 2014, Saita et 
al., 2004, Hollingsworth et al., 2006) 
Several approaches and guidelines are available for treatment of kidney stones, most 
of them choose the treatment based on the physicochemical properties of patient’s 
stones. However, assessment of physicochemical is not always feasible. Generally, 
guidelines agree on that pain management and hydration is part of the acute 
treatment of all types of stones. Initially, evaluation to exclude infection shall be 
obtained, then identification of location and size through imaging studies. 
Consequently, decisions to consider medical expulsive therapy or surgical 
interventions according to guidelines.  
All in all, treatment could depend on the experience and the culture of the treating 
physician for kidney stones. For the same location and size, physicians might put a 
patient under watchful waiting as a conservative measure, letting the stone to pass 
within a certain period with providing symptomatic relief. Other physicians may go 
for more advanced treatment options from the beginning such as interventional 
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options.  Medical expulsive therapy is a strategy used for facilitating stones passage 
through the urinary tract by using drugs such as alpha blockers or calcium channel 
blockers.  
Kidney stone disease is not considered a mortal disease anymore, however, it is a 
devastating disease. Recurrent intermittent pain episodes, surgical interventions, 
medication consumption and facing the risk of side effects, all of which affect the 
quality of life of the patients. (Rule et al., 2009, Donnally et al., 2011) 
As a complex disease, by means of symptoms diversity and individualized treatment 
with high risks of disease recurrence after treatment. Surgical management aims to 
treat the patient and eliminate the stones, medical management aims to treat and 
prevent recurrence of disease, also, minimizing the frequency of painful episodes and 
their acuity. (Penniston and Nakada, 2013) However, it is more relevant to patients to 
care about daily life and how the disease or its treatment is affecting their life. Hence, 
understanding and exploring the perceptions of the patients, expectations, and 
satisfaction towards the various treatment options will provide opportunities for 
healthcare improvement, cost reduction, design effective management, enhancing 
decision making by involving patients in the process. 
1.2 Kidney stone disease epidemiology  
As a disease that occurs in all parts of the world, the understanding of kidney stones 
disease epidemiology is crucial to specify the significance of the disease in each 
country worldwide. (Knoll, 2010)  Urolithiasis is regarded as the third most frequent 
urological disease.(Kovshilovskaya et al., 2012) Many studies showed that 
prevalence and incidence of kidney stones disease are increasing in all parts of the 
world.(Curhan, 2007, Lee et al., 2002, Soucie et al., 1994, Stamatelou et al., 2003, 
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Morgan and Pearle, 2016) Hence, reducing the risk of disease formation is possible 
by the understanding of its epidemiology, risk factors, and variations between 
countries and ethnicities.  
1.2.1 Prevalence and incidence of renal stones: A global picture  
Prevalence, the proportion of a population of having a disease or a characteristic, of 
kidney stones disease was reported to be increasing worldwide. While, the incidence, 
the number of new cases that develop in a given period of time, was reported to be 
increasing as well.(Noordzij et al., 2010) 
The risk factors that are population dependent made the variation in epidemiological 
disease profile of kidney stones between countries. (Romero et al., 2010b, Yasui et 
al., 2008, Alatab et al., 2016, Fisang et al., 2015). 
The variation in prevalence is demonstrated in the Afro-Asian stone forming belt as 
shown in Figure 1-1, which is an area of the world extends from the North African 
countries to the Arabian Gulf, Iran, India, and Malaysia down to the Philippines. In 
this area, the disease affects all age groups with a male-to-female ratio of 2:1 and 
prevalence of 10 - 15%, some studies reported up to 20%, and some studies reported 
lower values. (Fisang et al., 2015)  
A review by (Romero et al., 2010a) was made to capture the global picture of 
prevalence, incidence, and risk factors for kidney stones disease. By reviewing 
studies from more than 20 countries, it came to conclude that prevalence and 
incidence are increasing globally, where the changes in dietary habits had a key role 
in these effects.  
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It was reported that the disease formation in Western countries is high compared to 
the Eastern countries. (López and Hoppe, 2010) However, there were differences in 
disease formation from century to century and from decade to decade. This attributed 
to the development of treatment strategies and diagnostic measures. The occurrence 
of kidney stones in Asia in the 20th century was similar to the occurrence of kidney 
stones in Europe in the 19th century as reported by the study by Asper. (Asper, 1984)  
1.3 Etiology and factors influencing on kidney stones development  
Urolithiasis has no single or definite cause; it is considered as a multifactorial 
disease; several factors increase the risk of forming stones. (Pak, Resnick, & 
Preminger, 1997; Prince, Scardino, & Wolan, 1956) Different factors play a role in 
disease formation in different populations,such as: 
- Socio-economic status 
- Dietary habits and obesity 
- Dehydration 
- Digestive diseases 
Figure 1.1 Afro-Asian Stone Forming Belt (red area) “adopted and used 
with permission from (Fisang et al., 2015)” 
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- Geographical and environmental area 
- Racial differences 
- Family history 
This variation in risk factors around the world made the variation in epidemiological 
disease profile between countries.(Claros et al., 2012; Hughes & Caring for 
Australians with Renal, 2007; Romero et al., 2010a; Shoag, Tasian, Goldfarb, & 
Eisner, 2015) 
Gender plays a role in the development of kidney stones where the risk of having 
stones in male dominates over females without specified reasons in literature. 
Nevertheless, many studies reported that this ration is decreasing due to the 
increasing occurrence in females.(Strope, Wolf, & Hollenbeck, 2010) Furthermore, 
all age groups are at risk of kidney stones formation with a peak incidence of 35 – 45 
years that differs from country to country. In terms of racial differences, researchers 
found that it is higher in whites, followed by Hispanics, Blacks, and Asians. 
Though the relationship between overweight and kidney stones has limited studies, 
obesity and high body mass index found to be a risk factor for kidney stones in 
Japanese men. Moreover, members of a family with kidney stones history has two to 
three folds higher relative risk of having kidney stones compared to those who do not 
have history, genetic factors can play a role in this. (Yoshimura et al., 2016)   
Geographical or environmental aspects such as hot climate, daily lifestyle, low-
consumption of an adequate amount of water are causes of dehydration, which 
causes the concentration of urinary constituents.  
Also, dietary habits like over or under-consumption of calcium-containing nutrients, 
over-consumption of vitamin C products, digestive diseases and many other medical 
8 
 
conditions like insulin resistance and metabolic syndrome, all of which found to 
contribute in causing kidney stone disease.(de Oliveira, Hauschild, Leite, Baptista, & 
Carvalho, 2014)  
1.4 Classifications of kidney stones 
Treatment of kidney stones differs in one patient compared to another, based on the 
size, composition, or location of stones.(Asplin, 2008) Therefore, kidney stones 
diagnosis and management influenced by properties of the kidney stones that the 
patient has. Classifications of kidney stones are summarized in table 1-2. (Türk et al., 
2016a) 
9 
 
 
• Less than 5mm to  ≥ 25 mm
• Staghorn (Stones large enough to fill the renal calyces)
Size
• Radiopaque (Ca oxalate, Ca phosphate)
• Radiolucent (Uric acid, Ammonium Urate, Xanthine)
• Poor radiopacity
Radiology
• Bladder
• Kidney
• Urethra
• Ureter
• Pelvic-Ureteric Junction (PUJ)
• Vesicouretric Junction (VUJ)
Location
• Calcium Stones (Ca Oxalate, Ca Phosphate)
• Uric Acid
• Cystine
• Struvite (Magnesium ammonium phosphate) 
Composition
• Non-infectious Stone
• Infectious stone
• Genetic
Cause
Figure 1.2 Kidney stones classifications 
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1.5 Clinical presentation  
Patients with urolithiasis seek medical help usually complaining of loin pain or renal 
colic which is an acute onset of severe cramping and intermittent abdominal and 
flank pain. (Ahmad et al., 1991, Cole et al., 1988) This pain may often be 
accompanied by fever, dysuria, urgency, or nausea and vomiting.(Pedersen et al., 
2011) Nonetheless, even with no or minimal pain sensation, many patients hurry for 
physicians because of hematuria or sandy urine. Renal stones can also be 
asymptomatic, where diagnosis occur during a routine medical checkup or visiting 
for a non-urological disease (Wimpissinger et al., 2007) Common clinical 
presentations are summarized in Table 1-1. (Frassetto and Kohlstadt, 2011) 
Table 1.1 Common clinical presentations of patients with kidney stones 
Common Renal Stones Symptoms 
Dysuria (urinating small amount) 
Urgency (persistent need to urinate) 
Fever and chills 
Hematuria, sandy urine 
Nausea, vomiting 
Pain and cramps (abdominal, flank, loin, side) 
Pain in urination 
Asymptomatic 
 
Renal colic is episodic in nature; pain induction occurs when the stone blocking urine 
passage is trying to move due to peristaltic movement of the ureter or when the 
patient is trying to force urination. Moreover, the blockage of urine flow and urine 
retention cause hydroureter or hydronephrosis based on the obstruction location. 
Renal colic involves prostaglandin-mediated pain due to the elevated intra-pelvic 
pressure caused by obstruction of urinary flow and subsequent contraction of smooth 
muscle of ureter as an attempt to move and expel the stone.(Cole et al., 1988, Ahmad 
et al., 1991, Holdgate and Pollock, 2004) All of which, pain comes to the patient as 
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waves or episodes that lasts from minutes to up to one hour.(Pearle et al., 2014) 
Hence, renal colic is considered as an emergency that needs prompt action and 
causes the patient to seek medical attention.  
1.6 The role of the pharmacist in urology related issues 
Kidney stone management requires a thorough patient history, definitive diagnosis, 
supportive care, and possible surgical intervention. Long-term management focuses 
on addressing the underlying etiologies and preventing complications of treatment. 
(Mohammad et al., 2013) Pharmacists continue to identify drug-induced causes, 
promote public health information, and counsel patients on methods to avoid 
recurrent stone formation. Along with other health care professionals, pharmacists 
are of drug-induced causes and counsel patients to adhere to definitive therapies and 
recommended diets.  
Pharmacists develop interventions in urology including participating in ward rounds 
and making drug treatment plans for clean operations in urology, and extracting the 
medical records of inpatients who receive antibiotics in urology and assessing their 
responsible use. Also, participating in consultations on complicated infection cases in 
urology.(Zhou et al., 2015) 
Pharmacist team works with physicians to ensure provision of clinical support and 
affordable medication to meet needs and expectations of the patients. Among 
patients with kidney stones rates of adherence to thiazide diuretics, alkali citrate 
therapy and allopurinol, collectively referred to as preventive pharmacological 
therapy, are low. This lack of adherence may reduce the effectiveness of secondary 
prevention efforts, leading to poorer clinical health outcomes in patients with kidney 
stones. The consequences of nonadherence to preventive pharmacological therapy 
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among patients with kidney stones. To improve adherence further research is needed 
to understand patient and provider level factors that contribute to lower rates of 
adherence.(Dauw et al., 2016)  
The relationship between nephrolithiasis and urinary tract infections (UTIs) is 
complex and difficult to analyse both on a physiopathological and clinical point of 
view.(Zhou et al., 2015) 
Most kidney stones are composed of calcium oxalate or calcium phosphate, and they 
may lead to urinary obstruction, flank pain, hematuria, and an increased infection 
predisposition. Urinary tract infections (UTI) and urosepsis are complications which 
can precede or follow a kidney stone treatment. 
The relationship between urinary stones and UTIs is well known and has different 
clinical pictures, namely, stones that develop following UTIs (infection stones) and 
stones complicated by UTIs (stones with infection). (Miano et al., 2007)  Thus, there 
is agreement on the need for prophylaxis and antibiotic therapy, the most recent 
literature has shown excellent results with fluoroquinolones both in prophylaxis and 
therapy, concerning post-operative infection control after percutaneous as well as 
ureteroscopic removal of stones. No agreement has yet been reached on antibiotic 
prophylaxis modalities prior to percutaneous or ureteroscopic removal and its 
usefulness for ESWL.(Zanetti et al., 2008) Hence, antibiotic stewardship programme 
with pharmacist participation including real-time interventions can promote 
improved antibiotic-prescribing and significantly decrease costs.(Zhou et al., 
2015)  the prevalence of infection might also be different, depending on the pathogenic 
mechanism of nephrolithiasis and on the geographical, social and economic 
environment. 
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1.7 Study Objectives 
The current study divided into two parts 
1.7.1 The quantitative phase 
1. To determine the prevalence of kidney stones disease among patients admitted to 
Hospital Universiti Sains Malaysia (HUSM) in the period of 1st January 2012 to 
31st December 2016.  
2. To present the common modes of treatment options used by physicians to treat 
patients with kidney stones disease. 
3. To evaluate clinical characteristics of kidney stones patients in HUSM.  
1.7.2 The qualitative phase 
1. To explore patients’ satisfaction and experiences with the management of kidney 
stones disease. 
2. To explore patients’ perceptions of kidney stone disease and its treatment. 
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Along with the study objectives, the research took three phases (two quantitative and 
one qualitative) to achieve its objectives. The research flow chart is shown in Figure 
1.1. 
 
 
Figure 1.3 Research flow chart 
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1.8 Significance of the study 
• In a multi-ethnic country like Malaysia, there are very limited data about kidney 
stones, and the disease has no priority compared to other urological diseases.  This 
study will provide an insight and fresh information about the disease in Malaysia.  
• Studying the prevalence of kidney stones, modes of treatment, disease 
progression, comorbidities and clinical characteristics of kidney stones patients, can 
help the health care authorities in designing better strategies to provide effective 
treatment and preventive maneuvers. 
• Besides RCT or evidence-based health care as a guide for therapy selection, 
listening and investigate the stories about experiences and limitations of therapy is 
equally essential in the patient care. 
• Understanding the influence of social aspects, perceptions and patients’ 
satisfaction toward management of kidney stones will help in providing appropriate 
care and patient-education that ensures the best expected health outcomes. 
• Giving insights into the influence of social aspects, perceptions and patients’ 
satisfaction toward their stones management; the understanding of what is influential 
from the patients’ perspective and how far patients are satisfied with their disease 
management, what do they do to improve pain relief, how the disease is affecting 
their quality of life. All of this will give the ability to deliver optimum care, patient 
education, and therapeutic plans; which will ensure achieving their expectations with 
minimum let-downs and contribute to better outcomes and satisfaction.  
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1.9 Outline of the thesis 
This thesis is organized into the following sequence to address the study objectives: 
In Chapter 2, literature review presents a comprehensive background of kidney stone 
disease, clinical presentation, classification, investigations, and renal function with 
kidney stones. Nonetheless, the review had a focus on the epidemiology of the 
disease and the treatment options by international guidelines. Moreover, the chapter 
reviews evidence on the perceptions of stone formers, satisfaction toward disease 
management, and patient-reported outcomes importance in health-related quality of 
life.  
Chapter 3 addresses the methodology undertaken to attain the quantitative objectives 
of the research that lead to the results and outcomes. After discussion and 
interpretation of the results, eventually, limitations and conclusions were stated.  
Chapter 4 provides the qualitative research methodological approaches and sampling 
techniques implemented in the present study. Recruitment and the qualitative 
interviewing process of patients with kidney stones. Moreover, it presents how the 
qualitative data was managed and handled for interpretation and analysis. Eventually, 
discuss the emerged themes from analyzed interviews to come up with the 
conclusions.  
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CHAPTER 2:  
LITERATURE REVIEW 
2.1 Overview 
The current chapter aims to provide a comprehensive background information to 
guide the research objectives in chapter 1, in which the outcomes of the study will be 
discussed in Chapter 4, 5, and 6. 
This chapter begins with reviewing kidney stones disease, from the aspect of 
pathophysiology, etiology, symptomatic evaluation, and diagnostic investigations. 
Information regarding the epidemiology of kidney stones disease will be further 
discussed from a global perspective and Malaysian perspective. 
As management of renal stone disease varies based on several factors, herein, a 
review to summarize the evidence-based guidelines and current modes of treatments. 
Furthermore, there is a brief review to discuss the effect of kidney stones disease on 
the deterioration of kidney function.  
Finally, the chapter reviews relevant articles to the satisfaction of patients toward the 
treatment of kidney stones diseases such as patient-reported outcomes and health-
related quality of life of patients with kidney stones disease.  
Research articles and review articles that reported epidemiology of kidney stones 
disease, causes, treatment options or medication used among kidney stones disease 
patients, and literature reporting satisfaction or studying quality of life of kidney 
stones patients were included whereas the data published focusing on herbal products 
and dietary therapy were excluded as it is out of scope of this research. 
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2.2 Kidney stone disease epidemiology  
A population-based study in the United States of America (USA) to determine the 
disease prevalence over a 20-year period, involving USA residents in 1976 to 1980 
and USA residents in 1988 and 1994. It was found that disease formation was 
increasing between 1980 and 1994, where 1988 to 1994 had a prevalence of 5.2% 
and 1976 to 1980 of 3.8%, (p < 0.05). It was greater in males over females and 
strongly associated with ethnicity and residence area. (Stamatelou et al., 2003) 
The Kingdom of Saudi Arabia (KSA) had the highest disease prevalence all-over the 
world with a percentage of 20%. (Asper, 1984) The prevalence rate in KSA among 
males was of 8.1%. (Abdel-Halim et al., 1989). The study by (Abomelha et al., 1990) 
came to find that there is a seasonal variation kidney stones disease formation with a 
strong correlation between kidney stones and monthly temperature, also, the 
geographical area has a high atmospheric pressure was found to be correlated with 
disease formation. On the contrary, humidity did not show any correlation. As an 
Islamic country, data were analyzed peri-fasting month and peri-pilgrim period, no 
significant correlation was found. All in all, these findings were similar to studies in 
the same geographical area such as Iraq (Al-Dabbagh and Fahadi, 1977), Kuwait 
(Salem and ABU, 1969), and the United Arab Emirates (UAE) .(Husain et al., 1979)  
In a more recent study of the same geographical area of KSA, analysis of the records 
of urolithiasis cases in UAE for the period of 2007 to 2009 found that male to female 
ratio was 5.2:1. The study focused on the age of disease formation and clinical 
presentation. The mean age at onset was 33.1 ± 8.6 years. However, it did not find 
statistically significant differences in age. (Venkatramana et al., 2010) 
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In a study by Robertson et al; 2012, the study reviewed the kidney stone formation in 
the Middle East, the Arabian Gulf countries in particular. (Robertson, 2012) Having 
a high incidence of renal stones in the Gulf Countries, the review revealed that these 
findings attributed to high consumption of animal protein and high consumption of 
oxalate-containing food. Also, a hot and dry climate that causes dehydration and low 
volumes of urine was a factor of the higher incidence. Despite including studies from 
a limited period (1980 to 1990), (Robertson, 2012) many more recent studies 
reported the high consumption of animal protein in Arabian Gulf countries as well. 
(Musaiger et al., 2012, Ng et al., 2011) 
In Japan, kidney stones are one of the most common urological diseases as well. 
(Yoshimura et al., 2016) Using a nationwide survey, epidemiology of upper urinary 
tract stones in Japan was evaluated. Japanese reports have shown that a steady 
elevation in the incidence of urinary calculi and the age-adjusted annual incidence of 
upper urinary tract stones in 2005 was more than double the incidence in 1965. The 
study included almost all urologists in Japan, inclusion was to patients visited 
urologists in the year 2005 and diagnosed with kidney stones for the first time. 
Compared to a nationwide survey done between 1965 and 1995, the estimated annual 
incidence was 114.3 per 100,000 in 2005 compared to 53.8 per 100,000 in 1965 and 
92.5 in 1985 with a male to female ratio of 2.5:1.(Yoshida and Okada, 1990) In 
regard to age, the annual incidence had increased in all age groups. (Yasui et al., 
2008) 
Similarly, in Taiwan, the annual incidence was increasing with male patients being 
more dominant compared to female patients. The number of kidney stones cases in 
each 5-year period from 1956 to 1999 at a university hospital in Taiwan increased 
from ~65 cases/year between 1956 and 1960 to ~410 cases/year between 1996 and 
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1999. The lifestyle and dietary habits changes were attributed to the similarity 
between Taiwan and Western countries kidney stones patterns.  (Hsu et al., 2002) 
Based on the National Health Insurance Research Database of Taiwan, an 
epidemiological analysis was done to patients diagnosed with upper urinary tract 
stones between 1997 and 2010.  The prevalence was 7.38% with a male to female 
ratio of 1.55:1. The recurrence rate was 6.12% at one year and of 34.71% at 5 years, 
with males being of higher recurrence rate also. In regards to age, the peak 
prevalence was in the 60 to 69-year age. (Huang et al., 2013) 
In Hong Kong, a study was conducted to report the prevalence of renal stones, 
patients’ characteristics, and awareness towards prevention by surveying the general 
public using phone calls. A total of 1010 individual were surveyed in 2007, 25 of 
them reported to have a history of kidney stones disease, (2.5% point prevalence). 
Despite the relative quality of evidence, it showed results that are consistent with 
other studies, where the male had a higher percentage of having kidney stones with a 
ratio of 3:2 and older age groups were more common to have kidney stones 
especially 50 – 59 years old. The study also reported poor knowledge of proper 
strategies to prevent renal stones. Considerably, Hong Kong had lower prevalence  
(2.5%)(Chan et al., 2008) compared to countries in same geographical area, such as 
Seoul (3.5%)(hoe Kim et al., 2002), Japan (5.4%)(Yoshida and Okada, 1990), and 
Taiwan (7.38%)(Huang et al., 2013)  
Alatab et. al. published a review comparing between developing and developed 
world showing that the incidence of urolithiasis had a steady increase around the 
world. (Alatab et al., 2016) It was reported that urolithiasis incidence has been 
increasing in both developing and developed countries, however, younger age 
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population in the developing countries had higher risks of renal stones formation 
compared to developed countries. Also, developing countries had higher uric acid 
stones than developed countries.  
2.2.1 Kidney stones in Malaysia 
Malaysia is located in Southeast Asia, it consists of 13 states and 3 federal territories. 
With a population over 30 million, Malaysia has various ethnicities, namely, Malay, 
Chinese, Indian among minorities of other ethnicities. The healthcare in Malaysia has 
been considered as one of the best in the world. Also, Malaysia healthcare system 
was complemented by the United Nation development program and other developing 
counties should look up to it. A thorough literature review was done to learn about 
the epidemiology of the disease, however, the review failed to find recent studies. 
Apparently, the disease has no priorities to do studies about it, and there is no 
available statistics about it. A review published in 1990 by Sreenevasan was the 
latest pieces of information about kidney stones in Malaysia.  
In 1990, Sreenevasan presented the incidence of kidney stones in Malaysia by 
comparing between a study conducted in 1980 covered the years of 1962-1976 and a 
study conducted in 1989 covered the period of 1977-1981. It studied ethnicity, sex, 
and age distribution of kidney stones among the three major races of Malaysia 
(Chinese, Malay, and Indians). (Sreenevasan, 1981, Sreenevasan, 1990) It concluded 
that in Malaysia, the incidence of renal stones formation was increasing in the 
periods 1962-1966, 1967-1971, and 1977-1981. The study also concluded that there 
was no significant variation consistent with Malaysia population.(Sreenevasan, 1981, 
Sreenevasan, 1990) The study showed the increasing incidence between 1962 and 
1981; incidence of ~200 per 100,000 in 1961 was doubled to up to more than 400 per 
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100,000. Ethnicity, sex, and age distribution of more than four thousand diverse 
subjects with kidney stones showed ~48% Chinese, while ~37% were Malay and 
around 13% Indian. The highest incidence found to be between the ages of 30 to 50 
years old in all groups and female dominated by males with a male-to-female ratio of 
3:1 which is consistent with international findings. As shown in Figure 2-1. 
(Sreenevasan, 1990) 
Since there are no prevalence studies and no population-based studies on the 
incidence of kidney stones in Malaysia in the last two decades. Thus, several reviews 
and meta-analysis have been done by several researchers found in the health 
literature studying Malaysian results in their reviews (Romero et al., 2010b, Yasui et 
al., 2008, Sreenevasan, 1990, Alatab et al., 2016). Bearing in mind the evolving 
epidemiology of urinary tract stones and evolving nature of Malaysian population, 
including obsolete Malaysian information about renal stones will not capture or 
present evidence of high quality about the country. 
For example, Alatab et al in 2016 published a review using the same references 
showing that the incidence of urolithiasis had a steady increase, although it presented 
only the incidence of kidney and ureter stones without showing the incidence of 
stones in other parts of renal tracts, the included incidence was of the study made 
many decades ago.   
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Figure 2.1 Figures showing kidney stones disease distribution  
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2.3 Treatment of kidney stones disease 
This section provides a comprehensive summary of the treatment modalities for 
kidney stones disease. Many international guidelines, such as American Urology 
Association (AUA) and European Association of Urology (EAU), offer evidence-
based plans for evaluation, investigations, symptomatic management, surgical 
approaches, pharmacological therapy, and preventive measures. Table 2-1 
summarizes the medical and surgical treatment options for each renal stone type. 
Table 2.1 Summary of renal stones management strategies 
Stone type Procedures Medications 
Calcium  
Phosphate, 
Calcium 
 Oxalate 
ESWL* Allopurinol 
Open surgery Amiloride 
PCNL€ Cellulose Phosphate 
URS¥ Chlorothiazide 
 Chlorthalidone 
Cholestyramine 
Hydrochlorothiazide 
Magnesium citrate 
Potassium citrate 
Potassium magnesium citrate 
Potassium Phosphate 
Sodium Phosphate 
Trichlormethiazide 
Uric Acid ESWL* Allopurinol  
Open surgery Potassium citrate 
PCNL€  Sodium bicarbonate 
URS¥  
Struvite Open surgery 
 
Acetohydroxamic acid (AHA) 
Aluminum hydroxide gel 
Antibiotics   
Cystine Open surgery 
 
Amercaptopropionylglycine  
(tiopronin) 
Captopril  
d-penicillamine 
Sodium bicarbonate 
*ESWL: Extracorporeal shockwave lithotripsy,  
€PCNL: Percutaneous nephrolithotomy, ¥URS: Ureteroscopy  
 
